Literature DB >> 22736030

A polyglutamine expansion disease protein sequesters PTIP to attenuate DNA repair and increase genomic instability.

Hong Xiao1, Zhigang Yu, Yipin Wu, John Nan, Diane E Merry, JoAnn M Sekiguchi, David O Ferguson, Andrew P Lieberman, Gregory R Dressler.   

Abstract

Glutamine (Q) expansion diseases are a family of degenerative disorders caused by the lengthening of CAG triplet repeats present in the coding sequences of seemingly unrelated genes whose mutant proteins drive pathogenesis. Despite all the molecular evidence for the genetic basis of these diseases, how mutant poly-Q proteins promote cell death and drive pathogenesis remains controversial. In this report, we show a specific interaction between the mutant androgen receptor (AR), a protein associated with spinal and bulbar muscular atrophy (SBMA), and the nuclear protein PTIP (Pax Transactivation-domain Interacting Protein), a protein with an unusually long Q-rich domain that functions in DNA repair. Upon exposure to ionizing radiation, PTIP localizes to nuclear foci that are sites of DNA damage and repair. However, the expression of poly-Q AR sequesters PTIP away from radiation-induced nuclear foci. This results in sensitivity to DNA-damaging agents and chromosomal instabilities. In a mouse model of SBMA, evidence for DNA damage is detected in muscle cell nuclei and muscular atrophy is accelerated when one copy of the gene encoding PTIP is removed. These data provide a new paradigm for understanding the mechanisms of cellular degeneration observed in poly-Q expansion diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22736030      PMCID: PMC3441122          DOI: 10.1093/hmg/dds246

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  52 in total

1.  Comparison of Affymetrix GeneChip expression measures.

Authors:  Rafael A Irizarry; Zhijin Wu; Harris A Jaffee
Journal:  Bioinformatics       Date:  2006-01-12       Impact factor: 6.937

2.  Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.

Authors:  Libin Cui; Hyunkyung Jeong; Fran Borovecki; Christopher N Parkhurst; Naoko Tanese; Dimitri Krainc
Journal:  Cell       Date:  2006-10-06       Impact factor: 41.582

3.  In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets.

Authors:  Weiguo Zhai; Hyunkyung Jeong; Libin Cui; Dimitri Krainc; Robert Tjian
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

Review 4.  Transcriptional alterations and chromatin remodeling in polyglutamine diseases.

Authors:  Dominique Helmlinger; Làszlò Tora; Didier Devys
Journal:  Trends Genet       Date:  2006-09-05       Impact factor: 11.639

5.  Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.

Authors:  Aaron B Bowman; Seung-Yun Yoo; Nico P Dantuma; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2005-01-20       Impact factor: 6.150

6.  Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model.

Authors:  Zhigang Yu; Nahid Dadgar; Megan Albertelli; Kirsten Gruis; Cynthia Jordan; Diane M Robins; Andrew P Lieberman
Journal:  J Clin Invest       Date:  2006-09-14       Impact factor: 14.808

7.  Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein.

Authors:  Zhigang Yu; Nahid Dadgar; Megan Albertelli; Arno Scheller; Roger L Albin; Diane M Robins; Andrew P Lieberman
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

8.  Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.

Authors:  Elizabeth J Slow; Rona K Graham; Alexander P Osmand; Rebecca S Devon; Ge Lu; Yu Deng; Jacqui Pearson; Kuljeet Vaid; Nagat Bissada; Ronald Wetzel; Blair R Leavitt; Michael R Hayden
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-02       Impact factor: 11.205

Review 9.  Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).

Authors:  Masahisa Katsuno; Hiroaki Adachi; Masahiro Waza; Haruhiko Banno; Keisuke Suzuki; Fumiaki Tanaka; Manabu Doyu; Gen Sobue
Journal:  Exp Neurol       Date:  2006-03-02       Impact factor: 5.330

10.  Empirical array quality weights in the analysis of microarray data.

Authors:  Matthew E Ritchie; Dileepa Diyagama; Jody Neilson; Ryan van Laar; Alexander Dobrovic; Andrew Holloway; Gordon K Smyth
Journal:  BMC Bioinformatics       Date:  2006-05-19       Impact factor: 3.169

View more
  7 in total

1.  Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.

Authors:  Anna Pluciennik; Yuhong Liu; Elana Molotsky; Gregory B Marsh; Bedri Ranxhi; Frederick J Arnold; Sophie St-Cyr; Beverly Davidson; Naemeh Pourshafie; Andrew P Lieberman; Wei Gu; Sokol V Todi; Diane E Merry
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

2.  CAG RNAs induce DNA damage and apoptosis by silencing NUDT16 expression in polyglutamine degeneration.

Authors:  Shaohong Peng; Pei Guo; Xiao Lin; Ying An; Kong Hung Sze; Matthew Ho Yan Lau; Zhefan Stephen Chen; Qianwen Wang; Wen Li; Jacquelyne Ka-Li Sun; Sum Yi Ma; Ting-Fung Chan; Kwok-Fai Lau; Jacky Chi Ki Ngo; Kin Ming Kwan; Chun-Ho Wong; Sik Lok Lam; Steven C Zimmerman; Tiziano Tuccinardi; Zhong Zuo; Ho Yu Au-Yeung; Hei-Man Chow; Ho Yin Edwin Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

Review 3.  Molecular mechanisms underlying nucleotide repeat expansion disorders.

Authors:  Indranil Malik; Chase P Kelley; Eric T Wang; Peter K Todd
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-17       Impact factor: 113.915

Review 4.  Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.

Authors:  Frederick J Arnold; Diane E Merry
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

5.  Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.

Authors:  Lenore K Beitel; Carlos Alvarado; Shaza Mokhtar; Miltiadis Paliouras; Mark Trifiro
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

Review 6.  The central role of DNA damage and repair in CAG repeat diseases.

Authors:  Thomas H Massey; Lesley Jones
Journal:  Dis Model Mech       Date:  2018-01-30       Impact factor: 5.758

7.  Impaired Nuclear Export of Polyglutamine-Expanded Androgen Receptor in Spinal and Bulbar Muscular Atrophy.

Authors:  Frederick J Arnold; Anna Pluciennik; Diane E Merry
Journal:  Sci Rep       Date:  2019-01-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.